Evotaz (Atazanavir and Cobicistat)

Active ingredients · Atazanavir Sulfate, Cobicistat

Atazanavir and Cobicistat · Tablet · 300 mg / 150 mg

NDC

0003-3641

Route

Oral

Therapeutic class

Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor , Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor , UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]

Marketing category

NDA